A combined oral contraceptive affects mucosal SHIV susceptibility factors in a pigtail macaque model
Supporting Files
-
-
-
-
Available in CDC Stacks on
File Language:
English
Details
-
Journal Article:J Med Primatol
-
Description:Background
Injectable hormonal contraception may increase women's risk of HIV acquisition, and can affect biological risk factors in animal models of HIV. We established, for the first time, a model to investigate whether combined oral contraceptives (COC) alter SHIV susceptibility in macaques.
Methods
Seven pigtail macaques were administered a monophasic levonorgestrel (LNG)/ethinyl estradiol (EE) COC at 33% or 66% of the human dose for 60 days. Menstrual cycling, vaginal epithelial thickness and other SHIV susceptibility factors were monitored for a mean of 18 weeks.
Results
Mean vaginal epithelial thicknesses was 290.8 μm at baseline and 186.2 μm during COC (p=0.0141, Mann Whitney test). Vaginal pH decreased from 8.5 during to 6.5 post- treatment (0.0176 two-tailed t-test). Measured microflora was unchanged.
Conclusions
COC caused thinning of the vaginal epithelium and vaginal pH changes, which may increase SHIV susceptibility. 0.033 mg LNG + 0.0066 mg EE appeared effective in suppressing ovulation. -
Subjects:
- Article
- contraception
- SHIV
- susceptibility
- transmission risk
- Non-Human Primate (NHP)
- Animals
- Contraceptives, Oral, Combined
- Disease Models, Animal
- Disease Susceptibility
- Dose-Response Relationship, Drug
- Ethinyl Estradiol
- Female
- HIV Infections
- Levonorgestrel
- Macaca nemestrina
- Menstrual Cycle
- Mucous Membrane
- Simian Acquired Immunodeficiency Syndrome
- Simian Immunodeficiency Virus
- Vagina
-
Pubmed ID:25536296
-
Pubmed Central ID:PMC4355188
-
Document Type:
-
Funding:
-
Volume:44
-
Issue:2
-
Download URL:
-
File Type:
-
Collection(s):
-
Main Document Checksum:urn:sha-512:68352fdf2a60a8899bcf936b3989523d397cd087cc6b13e5e02068278e462475b9443edf8eb815bd51c212fa135bfb24f42213c0b9efc392b5e3353f4d52a483
Supporting Files
File Language:
English
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings, journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
CDC Public Access